Assoc. Prof. Georgi Iskrov
Centre for Health Technology Assessment and Analyses (CAHTA)
Economic modeling of cancer therapies - what is doable and what is meaningful?
Dr. Iñaki Gutiérrez
Health Technology Assessment international (HTAi)
What the new HTA definition means in terms of value analysis and procurement models
Dr. Andras Incze
Baden-Wuerttemberg Cooperative State University - Germany
International reference pricing as a driver of managed-entry agreements
Prof. Jaime Espín
Andalusian School of Public Health - Spain
Impact of discounts and rebates on managed entry agreements and pharmaceutical expenditures

Вашето устройство|операционна система не се поддържат! За достъп до виртуалния конгресен център, моля използвайте друго устройство.